Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-021796
Filing Date
2019-11-07
Accepted
2019-11-06 17:57:44
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20190930_10q.htm 10-Q 1352638
2 EXHIBIT 10.1 ex_162768.htm EX-10.1 59699
3 EXHIBIT 10.2 ex_162769.htm EX-10.2 8805
4 EXHIBIT 31.1 ex_162765.htm EX-31.1 9067
5 EXHIBIT 31.2 ex_162766.htm EX-31.2 9263
6 EXHIBIT 32.1 ex_162767.htm EX-32.1 7034
13 image102.jpg GRAPHIC 8772
  Complete submission text file 0001437749-19-021796.txt   5774956

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acrx-20190930.xml EX-101.INS 1197325
8 XBRL TAXONOMY EXTENSION SCHEMA acrx-20190930.xsd EX-101.SCH 60620
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20190930_cal.xml EX-101.CAL 44362
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20190930_def.xml EX-101.DEF 333618
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20190930_lab.xml EX-101.LAB 319056
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20190930_pre.xml EX-101.PRE 362773
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 191197558
SIC: 2834 Pharmaceutical Preparations